Skip to main content

Publications

Huang, Yunda, Lily Zhang, Amanda Eaton, Nonhlanhla N. Mkhize, Lindsay N. Carpp, Erika Rudnicki, Allan DeCamp, et al. “Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participants.” Hum Vaccin Immunother 18, no. 1 (December 31, 2022): 1908030. https://doi.org/10.1080/21645515.2021.1908030.

Full Text

Pajon, Rolando, Nicole A. Doria-Rose, Xiaoying Shen, Stephen D. Schmidt, Sijy O’Dell, Charlene McDanal, Wenhong Feng, et al. “SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination.” N Engl J Med 386, no. 11 (March 17, 2022): 1088–91. https://doi.org/10.1056/NEJMc2119912.

Full Text

Atmar, Robert L., Kirsten E. Lyke, Meagan E. Deming, Lisa A. Jackson, Angela R. Branche, Hana M. El Sahly, Christina A. Rostad, et al. “Homologous and Heterologous Covid-19 Booster Vaccinations.” N Engl J Med 386, no. 11 (March 17, 2022): 1046–57. https://doi.org/10.1056/NEJMoa2116414.

Full Text

Mu, Zekun, Kevin Wiehe, Kevin O. Saunders, Rory Henderson, Derek W. Cain, Robert Parks, Diana Martik, et al. “mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in mice.” Cell Rep 38, no. 11 (March 15, 2022): 110514. https://doi.org/10.1016/j.celrep.2022.110514.

Full Text

Chu, Laurence, Keith Vrbicky, David Montefiori, Wenmei Huang, Biliana Nestorova, Ying Chang, Andrea Carfi, et al. “Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial.” Nat Med, March 3, 2022. https://doi.org/10.1038/s41591-022-01739-w.

Full Text

Gay, Cynthia L., Katherine S. James, Marina Tuyishime, Shane D. Falcinelli, Sarah B. Joseph, Matthew J. Moeser, Brigitte Allard, et al. “Stable Latent HIV Infection and Low-level Viremia Despite Treatment With the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent Vorinostat.” J Infect Dis 225, no. 5 (March 2, 2022): 856–61. https://doi.org/10.1093/infdis/jiab487.

Full Text

Sahoo, Anusmita, Edgar A. Hodge, Celia C. LaBranche, Tiffany M. Styles, Xiaoying Shen, Narayanaiah Cheedarla, Ayalnesh Shiferaw, et al. “Structure-guided changes at the V2 apex of HIV-1 clade C trimer enhance elicitation of autologous neutralizing and broad V1V2-scaffold antibodies.” Cell Rep 38, no. 9 (March 1, 2022): 110436. https://doi.org/10.1016/j.celrep.2022.110436.

Full Text

Del Moral-Sánchez, Iván, Rebecca A. Russell, Edith E. Schermer, Christopher A. Cottrell, Joel D. Allen, Alba Torrents de la Peña, Celia C. LaBranche, et al. “High thermostability improves neutralizing antibody responses induced by native-like HIV-1 envelope trimers.” Npj Vaccines 7, no. 1 (February 28, 2022): 27. https://doi.org/10.1038/s41541-022-00446-4.

Full Text

Sangare, K., S. H. Hait, M. Moore, C. Hogge, T. Hoang, M. A. Rahman, D. J. Venzon, et al. “E4orf1 Suppresses E1B-Deleted Adenovirus Vaccine-Induced Immune Responses.” Vaccines 10, no. 2 (February 1, 2022). https://doi.org/10.3390/vaccines10020295.

Full Text